Start for free
Start for free
AM

AB Magnitude Ventures Group

North America, New Jersey, United States, Morristown

Description

AB Magnitude Ventures Group is an investment firm.

Investor Profile

AB Magnitude Ventures Group has made 4 investments, with 0 in the past 12 months and 25% as lead.

Stage Focus

  • Series A (50%)
  • Series C (25%)
  • Pre Seed (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Oncology
  • Artificial Intelligence (Ai)
  • Information Services
  • Saas
  • Software
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does AB Magnitude Ventures Group frequently co-invest with?

AC
Ascenta Capital
North America, New York, United States, New York
Co-Investments: 1
Alexandria Venture Investments
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 1
Catalio Capital Management
Catalio Capital Management
North America, New York, United States, New York
Co-Investments: 1
General Catalyst
General Catalyst
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Global BioAccess Fund
Global BioAccess Fund
North America, New York, United States, New York
Co-Investments: 1
CV
Creacion Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 1
Foresite Capital
Foresite Capital
North America, California, United States, San Francisco
Co-Investments: 1
BlackMars Capital
BlackMars Capital
Europe, Sachsen-Anhalt, Germany, Hessen
Co-Investments: 1
Colt Ventures
Colt Ventures
North America, Texas, United States, Dallas
Co-Investments: 1
Fidelity
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 1

What are some of recent deals done by AB Magnitude Ventures Group?

Myrobalan Therapeutics

Medford, Massachusetts, United States

Myrobalan Therapeutics is a biotech firm that develops oral neurorestorative therapies to reverse key brain dysfunctions and CNS conditions.

BiotechnologyHealth CareTherapeutics
Series AJan 10, 2024
Amount Raised: $24,000,000
Odyssey Therapeutics

Cambridge, Massachusetts, United States

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

BiotechnologyHealth CareOncologyTherapeutics
Series CDec 5, 2023
Amount Raised: $101,000,000
Oloren AI

San Diego, California, United States

Oloren AI offers molecular descriptor that leverages informations from millions of publically curated datasets.

Artificial Intelligence (AI)Information ServicesSaaSSoftware
Pre SeedAug 31, 2022
Amount Raised: $300,000
BAKX Therapeutics

Kingston, New York, United States

BAKX Therapeutics is a provider of cancer treatment.

BiotechnologyHealth CareMedicalOncologyTherapeutics
Series ANov 18, 2021
Amount Raised: $25,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator